» Articles » PMID: 36309101

Deep Domain Adversarial Learning for Species-Agnostic Classification of Histologic Subtypes of Osteosarcoma

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 2022 Oct 29
PMID 36309101
Authors
Affiliations
Soon will be listed here.
Abstract

Osteosarcomas (OSs) are aggressive bone tumors with many divergent histologic patterns. During pathology review, OSs are subtyped based on the predominant histologic pattern; however, tumors often demonstrate multiple patterns. This high tumor heterogeneity coupled with scarcity of samples compared with other tumor types render histology-based prognosis of OSs challenging. To combat lower case numbers in humans, dogs with spontaneous OSs have been suggested as a model species. Herein, a convolutional neural network was adversarially trained to classify distinct histologic patterns of OS in humans using mostly canine OS data during training. Adversarial training improved domain adaption of a histologic subtype classifier from canines to humans, achieving an average multiclass F1 score of 0.77 (95% CI, 0.74-0.79) and 0.80 (95% CI, 0.78-0.81) when compared with the ground truth in canines and humans, respectively. Finally, this trained model, when used to characterize the histologic landscape of 306 canine OSs, uncovered distinct clusters with markedly different clinical responses to standard-of-care therapy.

Citing Articles

Review of Molecular Technologies for Investigating Canine Cancer.

Kehl A, Aupperle-Lellbach H, de Brot S, van der Weyden L Animals (Basel). 2024; 14(5).

PMID: 38473154 PMC: 10930838. DOI: 10.3390/ani14050769.

References
1.
Selmic L, Burton J, Thamm D, Withrow S, Lana S . Comparison of carboplatin and doxorubicin-based chemotherapy protocols in 470 dogs after amputation for treatment of appendicular osteosarcoma. J Vet Intern Med. 2014; 28(2):554-63. PMC: 4857984. DOI: 10.1111/jvim.12313. View

2.
Nagamine E, Hirayama K, Matsuda K, Okamoto M, Ohmachi T, Kadosawa T . Diversity of Histologic Patterns and Expression of Cytoskeletal Proteins in Canine Skeletal Osteosarcoma. Vet Pathol. 2015; 52(5):977-84. DOI: 10.1177/0300985815574006. View

3.
Sangle N, Layfield L . Telangiectatic osteosarcoma. Arch Pathol Lab Med. 2012; 136(5):572-6. DOI: 10.5858/arpa.2011-0204-RS. View

4.
Ferrer L, Fondevila D, Rabanal R, Vilafranca M . Immunohistochemical detection of CD31 antigen in normal and neoplastic canine endothelial cells. J Comp Pathol. 1995; 112(4):319-26. DOI: 10.1016/s0021-9975(05)80013-1. View

5.
Beck J, Ren L, Huang S, Berger E, Bardales K, Mannheimer J . Canine and murine models of osteosarcoma. Vet Pathol. 2022; 59(3):399-414. PMC: 9290378. DOI: 10.1177/03009858221083038. View